Funding information Japan Society for the Promotion of Science, Grant/Award Number: JP17K09842 Highlights • Inactivating mutations of the ABCC8 gene usually cause hyperinsulinemic hypoglycemia. • We report a family in which people with the inactivating mutation have progressed hyperinsulinemic hypoglycemia to hyperglycemia. • Treatment with incretin-related drugs might be a useful therapeutic approach to hyperglycemia in people with the inactivating mutation.
No takes yet. Share an insight, caveat, or question.
Karatojima et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: